A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients.
Moreau A, Kervella D, Bouchet-Delbos L, Braudeau C, Saïagh S, Guérif P, Limou S, Moreau A, Bercegeay S, Streitz M, Sawitzki B, James B, Harden PN, Game D, Tang Q, Markmann JF, Roberts ISD, Geissler EK, Dréno B, Josien R, Cuturi MC, Blancho G; DIVAT consortium.
Moreau A, et al.
Kidney Int. 2023 Mar;103(3):627-637. doi: 10.1016/j.kint.2022.08.037. Epub 2022 Oct 26.
Kidney Int. 2023.
PMID: 36306921